KeyBanc raises HCA Healthcare price target to $490 from $435
The material target increase is bullish, though the limited gap between the target and posted price tempers the signal.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The material target increase is bullish, though the limited gap between the target and posted price tempers the signal.
What happened, with direct paths to the underlying reporting
KeyBanc raised its HCA target by about 13% to $490, roughly 6% above the posted price of $462.29. The stock was down 0.02% since the signal.
Target: $490
Posted price: $462.29
Analyst firm: KeyBanc
Analyst: Matthew Gillmor
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.